The information on this site is not intended to provide medical advice. Any questions should be directed to a healthcare provider.

As of January 1, 2025, ZULRESSO® (brexanolone)
is no longer commercially available in the U.S.

ZULRESSO may help

Postpartum depression (PPD) can take you away from special moments with your baby. Learn more about treatment for PPD with ZULRESSO® (brexanolone).


A chance at a new beginning in 2.5 days (60 hours)

Number one

First FDA-approved:

ZULRESSO® (brexanolone) is the first FDA-approved treatment for postpartum depression in individuals 15 and older.

Two and a half days

Fast results:

In clinical studies, moms treated with ZULRESSO experienced a greater reduction of depressive symptoms vs placebo in 2.5 days (60 hours).* Symptoms were measured at the beginning of treatment using a standard depression scale and again at the end of treatment.

Check mark

Maintained results:

In these studies, moms who took ZULRESSO generally still felt better 30 days after treatment began, as measured by a standard depression scale.* This 30-day measurement was also a preplanned part of the study.

*Individual results may vary.


The treatment experience

See what moms had to say about their experience with ZULRESSO treatment. Your experience may differ.

Photo of Mom, Lene
When I arrived at the facility for the first day of treatment…they welcomed me with open arms, everyone was really rallying around me. I didn’t expect that. I don’t think I’ve ever had that before. I really felt supported and cared for.
Watch stories from real moms

ZULRESSO Patient Brochure..

Looking for more information about ZULRESSO and treatment? Download the Patient Brochure or share it.